Central Nervous System Relapse After Stem Cell Transplantation in Adolescents and Young Adults with Acute Lymphoblastic Leukemia: A Single-Institution Experience

被引:8
作者
Kozak, Margaret M. [1 ]
Yoo, Christopher H. [1 ]
Gutkin, Paulina M. [1 ]
von Eyben, Rie [1 ]
Agarwal, Rajni [2 ]
Donaldson, Sarah S. [1 ]
Muffly, Lori [3 ]
Hiniker, Susan M. [1 ]
机构
[1] Stanford Canc Inst, Dept Radiat Oncol, 875 Blake Wilbur Dr, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Pediat, Div Stem Cell Transplantat & Regenerat Med, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Med, Div Blood & Bone Marrow Transplantat, Stanford, CA 94305 USA
关键词
ALL; TBI; transplant; CNS relapse; TOTAL-BODY IRRADIATION; CRANIAL BOOST; CHILDHOOD; REMISSION; SURVIVORS; REGIMENS; OUTCOMES; CHILDREN;
D O I
10.1089/jayao.2019.0121
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate outcomes and central nervous system (CNS) relapse in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL), who underwent total body irradiation (TBI) before allogeneic hematopoietic stem cell transplantation (allo-SCT). Methods: A total of 136 AYA patients with ALL who received TBI before allo-SCT between 1998 and 2018 were reviewed. Twenty patients received cranial radiation in their initial treatment before conditioning for transplant and were excluded. Competing risk analysis was used to estimate the cumulative incidence of relapse. Kaplan-Meier and log-rank tests were used to calculate overall survival (OS) and to identify factors predictive of relapse. OS and time to relapse were calculated from date of allo-SCT. Results: One hundred sixteen patients were included in the analysis. Median age was 27 years and median follow-up time was 42 months. Twenty-six patients suffered a disease relapse and 49 died, 26 of posttransplantation complications. The median time to relapse was 7 months and the 5-year OS was 60%. Seven patients had a CNS relapse: 4 of 20 patients (25%) with pre-SCT CNS disease had a post-allo-SCT CNS relapse compared to 3 of 97 (3.1%) without pre-SCT CNS disease. Median time to CNS relapse was 7 months. Patients with post-SCT CNS relapse had median OS of 19 months. Conclusions: AYA patients with CNS disease who undergo an allo-SCT have a high rate of CNS relapse. The addition of additional CNS-directed therapy to transplant protocols warrants further investigation.
引用
收藏
页码:166 / 171
页数:6
相关论文
共 50 条
  • [41] Outcomes in patients with acute lymphoblastic leukemia who underwent second allogeneic hematopoietic cell transplantation for relapse after first transplantation
    Tachibana, Takayoshi
    Tanaka, Masatsugu
    Hagihara, Maki
    Fujimaki, Katsumichi
    Kanamori, Heiwa
    Nakajima, Hideaki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (04) : 594 - 602
  • [42] Prognostic factors of children and adolescents with T-cell acute lymphoblastic leukemia after allogeneic transplantation
    Ishida, Hisashi
    Kato, Motohiro
    Kawahara, Yuta
    Ishimaru, Sae
    Najima, Yuho
    Kako, Shinichi
    Sato, Maho
    Hiwatari, Mitsuteru
    Noguchi, Maiko
    Kato, Keisuke
    Koh, Katsuyoshi
    Okada, Keiko
    Iwasaki, Fuminori
    Kobayashi, Ryoji
    Igarashi, Shunji
    Saito, Shoji
    Takahashi, Yoshiyuki
    Sato, Atsushi
    Tanaka, Junji
    Hashii, Yoshiko
    Atsuta, Yoshiko
    Sakaguchi, Hirotoshi
    Imamura, Toshihiko
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (03) : 457 - 468
  • [43] Patterns and Outcomes of Acute Central Nervous System Complications During Treatment of Childhood Acute Lymphoblastic Leukemia: A Single-center Experience
    Hamoda, Asmaa
    Bedair, Mohamed
    Semary, Samah Fathy
    Youssef, Ayda
    Hafez, Hanafy
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2024, 46 (02) : 72 - 79
  • [44] Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients with Central Nervous System Involvement
    Aoki, Jun
    Ishiyama, Ken
    Taniguchi, Shuichi
    Fukuda, Takahiro
    Ohashi, Kazuteru
    Ogawa, Hiroyasu
    Kanamori, Heiwa
    Eto, Tetsuya
    Iwato, Koji
    Sakamaki, Hisashi
    Morishima, Yasuo
    Nagamura, Tokiko
    Atsuta, Yoshiko
    Takami, Akiyoshi
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (12) : 2029 - 2033
  • [45] Extramedullary Relapse of Acute Myelogenous Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
    Yuda, Sayako
    Fuji, Shigeo
    Onishi, Akio
    Tanaka, Takashi
    Inamoto, Yoshihiro
    Kurosawa, Saiko
    Kim, Sung-Won
    Fukuda, Takahiro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (06) : 1152 - 1157
  • [46] Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia and the Role of MRD: A Single Centre Experience from India
    Divya Subburaj
    Lakshman Vaidyanathan
    Ramya Uppuluri
    Dhaarani Jayaraman
    Revathi Raj
    Indian Journal of Hematology and Blood Transfusion, 2018, 34 : 43 - 47
  • [47] Radiation-Free myeloablative allogeneic hematopoietic stem cell transplantation for adult acute lymphoblastic leukemia: A comparison of outcomes between patients with and without central nervous system involvement
    Esfandbod, Mohsen
    Enshaei, Mercedeh
    Monzavi, Seyed Mostafa
    Kabootari, Maryam
    Behfar, Maryam
    Hamidieh, Amir Ali
    LEUKEMIA RESEARCH, 2021, 111
  • [48] Central nervous system relapse prophylaxis in acute lymphoblastic leukemia (ALL) intrathecal chemotherapy with and without cranial irradiation
    Tamaddoni, Ahmad
    Nesheli, Hassan Mahmodi
    Bali, Mohammad Kazem Bakhshandeh
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2010, 1 (01) : 27 - 30
  • [49] Obesity as the initial manifestation of central nervous system relapse of acute lymphoblastic leukemia: Case report and literature review
    Zhang, Li-Dan
    Li, Yan-Hong
    Ke, Zhi-Yong
    Huang, Li-Bin
    Luo, Xue-Qun
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2012, 8 (01) : 151 - 153
  • [50] Multiple viral infections after haploidentical hematopoietic stem cell transplantation in a child with acute lymphoblastic leukemia
    Ernst, J.
    Sauerbrei, A.
    Krumbholz, A.
    Egerer, R.
    Mentzel, H. -J.
    Kurzai, M.
    Haefer, R.
    Beck, J. F.
    Gruhn, B.
    TRANSPLANT INFECTIOUS DISEASE, 2012, 14 (05) : E82 - E88